UPDATE - Citi Downgrades CardioNet (BEAT) from Neutral to Sell; Patient Volume Targets Set to Miss
Tweet Send to a Friend
UPDATE - Citi downgrades CardioNet (Nasdaq: BEAT) from Neutral to Sell. PT $6.
Citi analyst says, "We recently hosted BEAT ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Citi analyst says, "We recently hosted BEAT ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE